Daily Stock Opinions and Ratings

Opinions

Peter Imhof Kalytera Therapeutics KLY-X PAST TOP PICK Dec 22, 2010

(A Top Pick April 30/10. Down 21.62%.) Still Likes.

Peter Imhof

Owned

Unlock Rating

$0.145

Stock price when the opinion was issued

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

COMMENT

Has done very well. Been increasing on 2 primary themes. 1) Junior Colombian names have been very strong recently and 2) appear to have made an oil discovery where net oil play was significantly more than expected.

BUY

Could be results tomorrow. You are still playing slightly for some success. He prefers to get exploration for free. Columbia exposure.

HOLD

Disappointing result when they had a secondary zone come in on prognosis primary zone didn’t produce what they were hoping for. Will be drilling 5 wells in Colombia this year and 2 in Guatemala. Will have about 500 barrels a day production in about a month.

BUY

Colombian oil and gas. Pretty much dead money for the last while. Made a discovery worth between 500 and 1,000 BOE’s so will have quite a bit of cash flow in the next couple of months. Did a large financing for some wells that have very large targets so financing risks are gone.

BUY

Oil/gas exploration in Colombia. Was weak and bottomed at around $0.10. Did a $35 million fund raising and are fully cashed up. Drilling 5 wells this year beginning in the summer. Prospects are pretty good. (Doesn’t own in his fund but Sprott owns.)

HOLD

Drilling in Colombia. Has been an under performer. The big story is that they haven't been able to drill as quickly as they thought they would because of permitting. Until they drill and you find out what they have, hold on to what you have.

HOLD

Stock has really lagged. New management. Have about $0.04-$0.05 in cash on the balance sheet. Just waiting for permits to drill in Colombia. Thinks they have some good assets.

HOLD

Presently trading at cash value. Drilling up in Colombia right now and the new management team has come in to try to make sure they're not spending too much money too quickly. Will see drill results in the next few weeks.

BUY

Just announced a discovery in Columbia. Flow tested over 2000 barrels per day. This well could produce up to 5000 when brought into production. A very well distributed stock so it might not jump too fast. Company could get taken out.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Peter Imhof Kalytera Therapeutics KLY-X PAST TOP PICK Dec 22, 2010

You might be interested:

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Kalytera Therapeutics(KLY-X)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Chris Blumas

Stockchase Insights

Jim Cramer - Mad Money

Eric Nuttall

The Panic-Proof Portfolio (Stockchase Research)